Catalyst
Slingshot members are tracking this event:
Progenics (PGNX) Expects Data in Q1 2017 from Phase 2b Pivotal Trial of Azedra in Pheochromocytoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PGNX |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 30, 2017
Occurred Source:
http://ir.progenics.com/releasedetail.cfm?ReleaseID=1019338
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Azedra, Pheochromocytoma, Paraganglioma, Phase 2b
